Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HU.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JB.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JB.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JB.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.256ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.256ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.256ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.256NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.77ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.77ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.77NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.34ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.34NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.248ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.248ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.248ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.248NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.70ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.70ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.70NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.43ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.43NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.559ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.559ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.559ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.559NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.406ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.406ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.406ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.406NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.69ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used